View in EDS HTML Full Text PDF Full Text

Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia.

Saved in:

Bibliographic Details
Title:	Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia.
Authors:	Lin, Han‐Xin^1,2, Sjaarda, Jenny¹, Dyck, Jocob¹, Stringer, Randa¹, Hillis, Chris³, Harvey, Maria², Carter, Ronald^1,2, Ainsworth, Peter^4,5, Leber, Brian³, Pare, Guillaume^1,2,6,7,8,9, Sadikovic, Bekim^1,4,5
Source:	European Journal of Haematology. Apr2016, Vol. 96 Issue 4, p360-366. 7p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	09024441
DOI:	10.1111/ejh.12597